» Articles » PMID: 29696420

Pre-operative Use of Dexamethasone Does Not Reduce Incidence or Intensity of Bleaching-induced Tooth Sensitivity. A Triple-blind, Parallel-design, Randomized Clinical Trial

Overview
Specialty Dentistry
Date 2018 Apr 27
PMID 29696420
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This study evaluated the effect of the administration of pre-operative dexamethasone on tooth sensitivity stemming from in-office bleaching.

Materials And Methods: A triple-blind, parallel-design, randomized clinical trial was conducted on 70 volunteers who received dexamethasone or placebo capsules. The drugs were administered in a protocol of three daily 8-mg doses of the drug, starting 48 h before the in-office bleaching treatment. Two bleaching sessions with 37.5% hydrogen peroxide gel were performed with a 1-week interval. Tooth sensitivity (TS) was recorded on visual analog scales (VAS) and numeric rating scales (NRS) in different periods up to 48 h after bleaching. The color evaluations were also performed. The absolute risk of TS and its intensity were evaluated by using Fisher's exact test. Comparisons of the TS intensity (NRS and VAS data) were performed by using the Mann-Whitney U test and a two-way repeated measures ANOVA and Tukey's test, respectively.

Results: In both groups, a high risk of TS (Dexa 80% x Placebo 94%) was detected. No significant difference was observed in terms of TS intensity. A whitening of approximately 3 shade guide units of the VITA Classical was detected in both groups, which were statistically similar.

Conclusions: It was concluded that the administration pre-operatively of dexamethasone, in the proposed protocol, does not reduce the incidence or intensity of bleaching-induced tooth sensitivity.

Clinical Relevance: The use of dexamethasone drug before in-office bleaching treatment does not reduce incidence or intensity of tooth sensitivity.

Clinical Trial Registration Number: NCT02956070.

Citing Articles

Characterization and Evaluation of the Cytotoxicity of Pregabalin Gels for Oral Application.

Xavier G, de Meneses Costa Ferreira L, Passos M, Rodrigues A, de Castro Franco F, Silva C Pharmaceuticals (Basel). 2024; 17(9).

PMID: 39338331 PMC: 11435025. DOI: 10.3390/ph17091168.


Effect of preoperative systemic capsaicin on tooth sensitivity after in-office bleaching: A pilot study.

Samimi P, Kachuie M, Jafarian A, Shahtouri M, Khoroushi M Dent Res J (Isfahan). 2024; 21:36.

PMID: 39188401 PMC: 11346606.


Assessment of the effect of experimental gel of pregabalin associated with 35% hydrogen peroxide bleaching on bovine dental enamel: an in vitro study.

Xavier G, Gil G, Paes Y, de Meneses Costa Ferreira L, Silva C, Ribeiro-Costa R Odontology. 2024; 113(1):331-339.

PMID: 39060896 DOI: 10.1007/s10266-024-00978-2.


Effect of an experimental desensitizing gel on bleaching-induced tooth sensitivity after in-office bleaching-a double-blind, randomized controlled trial.

Vochikovski L, Favoreto M, Rezende M, Terra R, da Silva K, Farago P Clin Oral Investig. 2022; 27(4):1567-1576.

PMID: 36418502 PMC: 9685084. DOI: 10.1007/s00784-022-04778-2.


Post-Operative Sensitivity and Color Change Due to In-Office Bleaching With the Prior Use of Different Desensitizing Agents: A Systematic Review.

Krishnakumar K, Tandale A, Mehta V, Khade S, Talreja T, Aidasani G Cureus. 2022; 14(4):e24028.

PMID: 35547454 PMC: 9090214. DOI: 10.7759/cureus.24028.


References
1.
Leonard Jr R, Bentley C, Eagle J, Garland G, Knight M, Phillips C . Nightguard vital bleaching: a long-term study on efficacy, shade retention. side effects, and patients' perceptions. J Esthet Restor Dent. 2002; 13(6):357-69. DOI: 10.1111/j.1708-8240.2001.tb01021.x. View

2.
Dahl J, Pallesen U . Tooth bleaching--a critical review of the biological aspects. Crit Rev Oral Biol Med. 2003; 14(4):292-304. DOI: 10.1177/154411130301400406. View

3.
Bjornson C, Klassen T, Williamson J, Brant R, Mitton C, Plint A . A randomized trial of a single dose of oral dexamethasone for mild croup. N Engl J Med. 2004; 351(13):1306-13. DOI: 10.1056/NEJMoa033534. View

4.
Giniger M, Macdonald J, Ziemba S, Felix H . The clinical performance of professionally dispensed bleaching gel with added amorphous calcium phosphate. J Am Dent Assoc. 2005; 136(3):383-92. DOI: 10.14219/jada.archive.2005.0181. View

5.
Rhen T, Cidlowski J . Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. N Engl J Med. 2005; 353(16):1711-23. DOI: 10.1056/NEJMra050541. View